SOUTHWEST ONCOLOGY GROUP/UNIVERSITY OF CALIFORNIA, DAVIS
SOUTHWEST ONCOLOGY GROUP/UNIVERSITY OF CALIFORNIA, DAVIS
批准号:
6848158
负责人:
DAVID R GANDARA
金额:
$10.88万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-01 至 2004-03-31
关键词:
antineoplasticsbleomycinbone marrow transplantationbrain neoplasmsbreast neoplasmscancer information systemcancer preventioncancer registry /resourcecis platinum compoundclinical researchclinical trialscombination cancer therapycombination chemotherapycooperative studycyclophosphamidedoxorubicindrug resistancefemale reproductive system neoplasmfludarabinegastrointestinal neoplasmshead /neck neoplasmhormone therapyhuman subjecthuman therapy evaluationifosfamideleukemialung neoplasmslymphomameeting /conference /symposiummelanomamultiple myelomaneoplasm /cancer chemotherapyneoplasm /cancer diagnosisneoplasm /cancer epidemiologyneoplasm /cancer geneticsneoplasm /cancer immunotherapyneoplasm /cancer radiation therapyneoplasm /cancer surgeryoncology nursingpaclitaxelpancreas neoplasmspathologyprognosisprostate neoplasmsquality of lifesarcomatamoxifentissue resource /registryurinary tract neoplasmswomen&aposs health
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Description: This is a dynamic, multicenter and multidisciplinary site with
high accrual (average 200/year, highest 2-4 percent of all SWOG
institutions) with an extensive CGOP, including the Kaiser system, and a
large VA/Air Force site. During the last cycle there have been increasing
scientific contributions, Group leadership, provision of special resources,
and pilot studies which have been translated into SWOG protocols. Despite
excellent performance, it has been functioning with less than adequate
support. This has led to several periods of a self-imposed cap on
registration until all data becomes current. The cancer program has been
designated by the University as a Center of Excellence, and the physical
facilities seem excellent. This level of activity has been maintained in an
environment of 90 percent managed care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UCDCCC NCTN UG1 PROGRAM
-
批准号:9888340
-
项目类别:
-
资助金额:$52.16万
-
财政年份:2019
-
负责人:DAVID R GANDARA
-
依托单位:
UCDCCC NCTN UG1 PROGRAM
-
批准号:10357788
-
项目类别:
-
资助金额:$55.73万
-
财政年份:2019
-
负责人:DAVID R GANDARA
-
依托单位:
UCDCCC NCTN UG1 PROGRAM
-
批准号:10584617
-
项目类别:
-
资助金额:$49.49万
-
财政年份:2019
-
负责人:DAVID R GANDARA
-
依托单位:
UCDCCC NCTN U10 Program
-
批准号:8838065
-
项目类别:
-
资助金额:$63.02万
-
财政年份:2014
-
负责人:DAVID R GANDARA
-
依托单位:
UCDCCC NCTN U10 Program
-
批准号:8605734
-
项目类别:
-
资助金额:$70.03万
-
财政年份:2014
-
负责人:DAVID R GANDARA
-
依托单位:
UCDCCC NCTN U10 Program
-
批准号:9128209
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2014
-
负责人:DAVID R GANDARA
-
依托单位:
TAS::75 0849::TAS EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:8352517
-
项目类别:
-
资助金额:$46.96万
-
财政年份:2011
-
负责人:DAVID R GANDARA
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:8845057
-
项目类别:
-
资助金额:$98.77万
-
财政年份:2011
-
负责人:DAVID R GANDARA
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:9038815
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2011
-
负责人:DAVID R GANDARA
-
依托单位:
TAS::75 0849::TAS EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:8499157
-
项目类别:
-
资助金额:$109.1万
-
财政年份:2011
-
负责人:DAVID R GANDARA
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:8737143
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2011
-
负责人:DAVID R GANDARA
-
依托单位:--
Early Therapeutics Development with Phase II Emphasis
-
批准号:8014373
-
项目类别:
-
资助金额:$14.68万
-
财政年份:2006
-
负责人:DAVID R GANDARA
-
依托单位:
Early Therapeutics Development with Phase II Emphasis
-
批准号:8328531
-
项目类别:
-
资助金额:$90.79万
-
财政年份:2006
-
负责人:DAVID R GANDARA
-
依托单位:
TAS:: 75 0850 ::TAS RECOVERY ACT - ACTNOW CLINICAL TRIAL 8155
-
批准号:7933254
-
项目类别:
-
资助金额:$94.25万
-
财政年份:2006
-
负责人:DAVID R GANDARA
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:7543356
-
项目类别:
-
资助金额:$86.84万
-
财政年份:2006
-
负责人:DAVID R GANDARA
-
依托单位:--
Early Therapeutics Development with Phase II Emphasis
-
批准号:7789081
-
项目类别:
-
资助金额:$10.36万
-
财政年份:2006
-
负责人:DAVID R GANDARA
-
依托单位:
PHASE III TRIAL OF CISPLATIN & IRINOTECAN VS CISPLATIN & ETOPOSIDE IN PATIENTS W
-
批准号:6975644
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2004
-
负责人:DAVID R GANDARA
-
依托单位:
PHASE I TRIAL OF E7389 (HALICHONDRIN B ANALOG)IN PATIENTS WITH ADVANCEDSOLID TUM
-
批准号:6975646
-
项目类别:
-
资助金额:$0.76万
-
财政年份:2004
-
负责人:DAVID R GANDARA
-
依托单位:
DOCETAXEL FOR METASTATIC BREAST CANCER IN PATIENTS AGED 70 YEARS & OLDER (& YOUN
-
批准号:6975645
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2004
-
负责人:DAVID R GANDARA
-
依托单位:
PHASE I STUDY OF STI571 IN PATIENTS WITH MALIGNANCIES & VARYING DEGREES OF LIV
-
批准号:6975647
-
项目类别:
-
资助金额:$0.46万
-
财政年份:2004
-
负责人:DAVID R GANDARA
-
依托单位:
海外基金